FDA narrows use of Stryker Wingspan brain stent
12:18 EDT 8 Aug 2012 | Reuters
WASHINGTON (Reuters) - U.S. health regulators said on Wednesday they would limit the use of Stryker Corp's artery-opening stent for the brain, based on new data and safety information.
Original Article: FDA narrows use of Stryker Wingspan brain stent
More From BioPortfolio on "FDA narrows use of Stryker Wingspan brain stent"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
